文献速递贫血与红细胞疾病

美国成人地中海贫血人群更新:CDC地中海贫血治疗中心报告

An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
PubMed 文献 · Br J Haematol · 2021-11-14

该报告基于CDC支持的地中海贫血治疗中心(TTC)纵向数据,比较了75例40岁以上与201例18-39岁成人地中海贫血患者。年长组铁相关合并症和输血相关并发症更多,年轻组成人则以亚裔为主、存在肝心铁过载并接受联合祛铁治疗。作者认为需要综合照护和定期调查以确保最佳健康并获取新兴疗法。

要点

  • 年长成人(>40岁,n=75)铁相关合并症和输血相关并发症更多。
  • 年轻成人(18-39岁,n=201)存在肝铁和心铁过量,并接受联合祛铁治疗。
  • 年轻成人以亚裔为主,反映移民人口构成。

核心结论

  • 综合照护和定期调查对于确保最佳健康和获取新兴疗法是必要的。

研究设计与样本

  • CDC支持美国地中海贫血治疗中心(TTC)汇编地中海贫血患者纵向信息,比较40岁以上成人(n=75)与18-39岁年轻成人(n=201)两个队列。

主要发现

  • 年长成人队列(n=75)铁相关合并症和输血相关并发症数量更多。
  • 年轻成人队列(n=201)存在肝铁和心铁过量,并接受联合祛铁治疗。
  • 年轻成人队列族裔构成以亚裔为主,反映移民人口构成。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thalassaemia is caused by genetic globin defects leading to anaemia, transfusion-dependence and comorbidities. Reduced survival and systemic organ disease affect transfusion-dependent thalassaemia major and thalassaemia intermedia. Recent improvements in clinical management have reduced thalassaemia mortality. The therapeutic landscape of thalassaemia may soon include gene therapies as functional cures. An analysis of the adult US thalassaemia population has not been performed since the Thalassemia Clinical Research Network cohort study from 2000 to 2006. The Centers for Disease Control and Prevention supported US thalassaemia treatment centres (TTCs) to compile longitudinal information on individuals with thalassaemia. This dataset provided an opportunity to evaluate iron balance, chelation, comorbidities and demographics of adults with thalassaemia receiving care at TTCs. Two adult cohorts were compared: those over 40 years old (n = 75) and younger adults ages 18-39 (n = 201). The older adult cohort was characterized by higher numbers of iron-related comorbidities and transfusion-related complications. By contrast, younger adults had excess hepatic and cardiac iron and were receiving combination chelation therapy. The ethnic composition of the younger cohort was predominantly of Asian origin, reflecting the demographics of immigration. These findings demonstrate that comprehensive care and periodic surveys are needed to ensure optimal health and access to emerging therapies.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Chapin J, Cohen AR, Neufeld EJ, et al. An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres. Br J Haematol. 2021. PMID: 34775608. doi:10.1111/bjh.17920

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。